Home Cart 0 Sign in  
X

[ CAS No. 214614-81-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 214614-81-0
Chemical Structure| 214614-81-0
Chemical Structure| 214614-81-0
Structure of 214614-81-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 214614-81-0 ]

Related Doc. of [ 214614-81-0 ]

Alternatived Products of [ 214614-81-0 ]

Product Details of [ 214614-81-0 ]

CAS No. :214614-81-0 MDL No. :MFCD06804929
Formula : C5H7BrN2O Boiling Point : -
Linear Structure Formula :- InChI Key :REUWXYIZJBMWPB-UHFFFAOYSA-N
M.W : 191.03 Pubchem ID :16640642
Synonyms :

Calculated chemistry of [ 214614-81-0 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.4
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 37.16
TPSA : 38.05 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.34 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.38
Log Po/w (XLOGP3) : 0.17
Log Po/w (WLOGP) : 0.64
Log Po/w (MLOGP) : 0.29
Log Po/w (SILICOS-IT) : 0.74
Consensus Log Po/w : 0.64

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.41
Solubility : 7.42 mg/ml ; 0.0389 mol/l
Class : Very soluble
Log S (Ali) : -0.53
Solubility : 56.8 mg/ml ; 0.297 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.5
Solubility : 6.05 mg/ml ; 0.0317 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.8

Safety of [ 214614-81-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 214614-81-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 214614-81-0 ]
  • Downstream synthetic route of [ 214614-81-0 ]

[ 214614-81-0 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 2075-45-8 ]
  • [ 540-51-2 ]
  • [ 214614-81-0 ]
YieldReaction ConditionsOperation in experiment
86% With potassium hydroxide; potassium iodide In ethanol at 155℃; for 8 h; microwave The mixture of 8d (400mg, 2.72mmol), KI (671mg, 4.04mmol), KOH (290mg, 5.2mmol) and 22a (625mg, 5.0mmol) in EtOH (1OmL) were reacted under microwave condition at 1550C for 8h. After the reaction was complete, the mixture was cooled, filtered and evaporated. The residue was dissolved in 2OmL of EtOAc 15 and washed with 2OmL of water, dried over Na2SO4 and concentrated to give 22b (0.45g, 86percent yield) as yellow oil.
65% With tetra-(n-butyl)ammonium iodide; caesium carbonate In N,N-dimethyl-formamide at 90℃; for 2 h; To a solution of 4-bromo-1H-pyrazole (1.00 g, 6.80 mmol) in 20 mL of DMF was successively added 2-bromoethanol (0.53 mL, 7.48 mmol), Cs2CO3 (2.66 g, 8.16 mmol) and TBAI (503 mg, 1.36 mmol). The resulting mixture was heated at 90 °C for 2 h and diluted with 60 mL of water. The mixture was extracted with EA (3 × 100 mL). The combined organic layer was washed with water (3 × 50 mL), brine (60 mL), dried over anhydrous Na2SO4 and concentrated under vacuum. The crude product was purified by flash column chromatography (0-30percent EA/PE gradient) to afford 27 as light yellow oil in 65percent yield. 1H NMR (300 MHz, CDCl3) δ 7.49 (s, 1H), 7.48 (s, 1H), 4.23 (t, J = 4.8 Hz, 2H), 3.99 (t, J = 4.8 Hz, 2H), 2.73 (br, 1H).
Reference: [1] Patent: WO2008/88881, 2008, A1, . Location in patent: Page/Page column 47
[2] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 21, p. 6804 - 6820
  • 2
  • [ 96-49-1 ]
  • [ 2075-45-8 ]
  • [ 214614-81-0 ]
YieldReaction ConditionsOperation in experiment
34%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.5 h;
Stage #2: at 20℃;
General Procedure 77
To a stirred solution of 4-bromo-1H-pyrazole in DMF was added sodium hydride at room temperature.
The mixture was stirred for 30 minutes, [1,3]dioxolan-2-one was added, the mixture was stirred and slowly warmed to room temperature.
The reaction was monitored by TLC.
After the reaction was done, EtOAc was added, washed with saturated NaHCO3, water and brine, dried with Na2SO4, filtered and concentrated.
The residue was purified by silica gel, eluants EtOAc and DCM 10percent, to give 2-(4-Bromo-pyrazol-1-yl)-ethanol 0.22 g, yield 34percent. 1H NMR (400 MHz, chloroform-D) δ ppm 7.49 (s, 1H) 7.46 (s, 1H) 4.18-4.23 (m, 2H) 3.93-3.98 (m, 2H) 3.09 (s, 1H).
34%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.5 h;
Stage #2: at 20℃;
To a stirred solution of 4-bromo-1 H-pyrazole in DMF was added sodium hydride at room temperature. The mixture was stirred for 30 minutes, [1,3]dioxolan-2-one was added, the mixture was stirred and slowly warmed to room temperature. The reaction was monitored by TLC. After the reaction was done, EtOAc was added, washed with saturated NaHCO3, water and brine, dried with Na2SO4, filtered and concentrated. The residue was purified by silica gel, eluants EtOAc and DCM 10percent, to give 2-(4-Bromo-pyrazol-1-yl)-ethanol 0.22 g, yield 34percent. 1H NMR (400 MHz, chloroform-D) 6 ppm 7.49 (s, 1 H) 7.46 (s, 1 H) 4.18 - 4.23 (m, 2 H) 3.93 - 3.98 (m, 2 H) 3.09 (s, 1 H).
Reference: [1] Patent: US2006/46991, 2006, A1, . Location in patent: Page/Page column 71
[2] Patent: WO2006/21881, 2006, A2, . Location in patent: Page/Page column 84
  • 3
  • [ 2075-45-8 ]
  • [ 1072-53-3 ]
  • [ 214614-81-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 9, p. 4115 - 4134
  • 4
  • [ 214614-81-0 ]
  • [ 1040377-08-9 ]
YieldReaction ConditionsOperation in experiment
26.6%
Stage #1: With potassium acetate In N,N-dimethyl-formamide for 0.166667 h;
Stage #2: at 80℃;
To a solution of 22b (0.45g, 2.36mmol) and bis(pinacolato)diboron (0.718g, 2.83mmol) in DMF (2OmL), was added KOAc (0.694g, 7.08mmol). The mixture was 0 degassed with N2, stirred for 1 Omin and added Pd(dppf)Cl2 (58mg, 0.071 mmol). The mixture was degassed with N2 and stirred at 8O0C overnight. DMF was removed and the residue was purified by column chromatography (EA:PE=1 :10) to afford of 22c (149mg, 26.6percent yield).
Reference: [1] Patent: WO2008/88881, 2008, A1, . Location in patent: Page/Page column 47
[2] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 21, p. 6804 - 6820
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 214614-81-0 ]

Bromides

Chemical Structure| 71229-85-1

[ 71229-85-1 ]

4-Bromo-1-ethyl-1H-pyrazole

Similarity: 0.88

Chemical Structure| 82231-53-6

[ 82231-53-6 ]

2-(4-Bromo-1H-pyrazol-1-yl)acetic acid

Similarity: 0.87

Chemical Structure| 313735-62-5

[ 313735-62-5 ]

4-Bromo-1-isopropylpyrazole

Similarity: 0.82

Chemical Structure| 925224-08-4

[ 925224-08-4 ]

2-(4-Bromo-1H-pyrazol-1-yl)acetonitrile

Similarity: 0.81

Chemical Structure| 1072944-71-8

[ 1072944-71-8 ]

Methyl 2-(4-bromo-1H-pyrazol-1-yl)acetate

Similarity: 0.80

Alcohols

Chemical Structure| 6314-23-4

[ 6314-23-4 ]

2-(1-Pyrazolyl)ethanol

Similarity: 0.79

Chemical Structure| 98484-49-2

[ 98484-49-2 ]

3-(1H-Pyrazol-1-yl)propane-1,2-diol

Similarity: 0.72

Chemical Structure| 948571-47-9

[ 948571-47-9 ]

2-(4-Amino-1H-pyrazol-1-yl)ethanol

Similarity: 0.69

Chemical Structure| 84407-13-6

[ 84407-13-6 ]

2-(3-Amino-1H-pyrazol-1-yl)ethanol

Similarity: 0.68

Chemical Structure| 84547-61-5

[ 84547-61-5 ]

(1-Methyl-1H-pyrazol-5-yl)methanol

Similarity: 0.67

Related Parent Nucleus of
[ 214614-81-0 ]

Pyrazoles

Chemical Structure| 71229-85-1

[ 71229-85-1 ]

4-Bromo-1-ethyl-1H-pyrazole

Similarity: 0.88

Chemical Structure| 82231-53-6

[ 82231-53-6 ]

2-(4-Bromo-1H-pyrazol-1-yl)acetic acid

Similarity: 0.87

Chemical Structure| 313735-62-5

[ 313735-62-5 ]

4-Bromo-1-isopropylpyrazole

Similarity: 0.82

Chemical Structure| 925224-08-4

[ 925224-08-4 ]

2-(4-Bromo-1H-pyrazol-1-yl)acetonitrile

Similarity: 0.81

Chemical Structure| 1072944-71-8

[ 1072944-71-8 ]

Methyl 2-(4-bromo-1H-pyrazol-1-yl)acetate

Similarity: 0.80